Incollaboration with WALA, the Translational Center at Fraunhofer ISC is developing anovel conjunctival model that enables theprecise analysis of inflammatory processes on the surface of the eye. Robust and scalable test systems allow active ingredients and complex drugs to be investigated under controlled but application-relevant conditions.

Are you working on similar topics? We would be happy to support you!

Our innovative, patented 3D fibrous polyamide membrane forstromal in vitro tissue models offers a biomimetic structure with high porosity and bioactivity. It supports cell migration and the synthesis of human tissue.

Thisversatile solution is suitable formodels such as skin, small intestine andcolon andenables animal-free research.

Further information is available here in the PDF for download.

Silicic acids, which are found in rice and bamboo, are important for our lives because they have a biostimulating effect on the body and the environment. At Fraunhofer ISC,sustainable, biodegradable materials are being developed from silicic acid that accelerate the body's regeneration and promote health. Dr. Bastian Christ will be glad to tell you more about the sustainable synthesis of biodegradable materials for life science applications!

The Fraunhofer Translation Center for Regenerative Therapies (TLC-RT) is taking overepiCS^® technology from Henkel AG & Co. KGaA, ensuring the availability of internationally standardized epidermis models. TheseOECD-validated tissue models offer a reliable alternative for evaluating skin reactions to chemical substances and contribute to the safety of cosmetics and pharmaceuticals.

The ISC biomaterial team is generating abioresorbable RENACER^® material platform for anovel vegan, biodegradable hair fixative from IPPM Technologies GmbH.

for automatized and standardized fabrication of complex living tissues

Together with its research partner Kneipp, the TLC-RT team is investigatingprotective as well as regenerative effects of various plant oils onin vitro skin models developed in-house. Thesescreenings can be carried outquickly, flexibly andwithout animal testing.

• 3D Bioprinting
• Regenerative Biomaterials
• In vitro and in vivo diagnostics
• Drug Delivery and Future Technologies

• Standardizedin vitro test systems
• Disease models
• hiPSC technologies

Our newsletters keep you up to date on the latest developments and offers at our institute.

Whether research projects, workshops, or events − if you would like to receive information about Fraunhofer ISC activities three to four times a year by e-mail, please subscribe to our

Email Newsletter

Do you prefer social media channels? Then subscribe to our monthly

Linkedin Newsletter